Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 225 of 230 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/20/20
End: 12/04/21
Due: 12/04/22
Phase: N/A
Priority: Normal
Start: 12/17/23
End: 06/27/24
Due: 06/27/25
Phase: N/A
Priority: Normal
Start: 10/30/23
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 07/01/23
End: 11/01/23
Due: 11/01/24
Phase: N/A
Priority: Normal
Start: 12/26/24
End: 03/31/25
Due: 03/31/26
Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients
Phase: N/A
Priority: Normal
Start: 03/01/19
End: 11/01/24
Due: 11/01/25
Phase: N/A
Priority: Normal
Start: 07/30/23
End: 05/30/24
Due: 05/30/25
Phase: N/A
Priority: Normal
Start: 07/15/23
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 11/01/23
End: 08/18/24
Due: 08/18/25
Phase: N/A
Priority: Normal
Start: 02/01/23
End: 01/30/24
Due: 01/30/25
Phase: N/A
Priority: Normal
Start: 04/23/23
End: 12/27/23
Due: 12/27/24
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 03/05/22
Due: 03/05/23
Phase: N/A
Priority: Normal
Start: 03/01/19
End: 11/04/19
Due: 11/04/20
Phase: N/A
Priority: Normal
Start: 07/30/23
End: 10/30/23
Due: 10/30/24
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 05/01/20
Due: 05/01/21
Phase: N/A
Priority: Normal
Start: 01/04/19
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 11/01/22
Due: 11/01/23
Phase: N/A
Priority: Normal
Start: 10/01/18
End: 03/15/19
Due: 03/15/20
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 09/30/23
Due: 09/30/24
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 03/30/25
Due: 03/30/26
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 05/30/24
Due: 05/30/25
Phase: N/A
Priority: Normal
Start: 03/15/20
End: 04/15/20
Due: 04/15/21
Phase: N/A
Priority: Normal
Start: 06/09/24
End: 04/01/25
Due: 04/01/26
Phase: N/A
Priority: Normal
Start: 09/12/20
End: 12/01/20
Due: 12/01/21
Phase: N/A
Priority: Normal
Start: 04/01/20
End: 09/30/20
Due: 09/30/21